Showing results (241-250 of 5,471) with videos related to
Sort By:
Pageof 548
International Journal of Hematology|November 26, 2021
An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphomaMomoko Nishikori, Yasufumi Masaki, Nobuharu Fujii, et al.International Journal of Hematology|March 12, 2021
Effect of hypofibrinogenemia on obstetrical disseminated intravascular coagulation in Japan in 2018: a multicenter retrospective cohort studyMamoru Morikawa, Shigetaka Matsunaga, Shintaro Makino, et al.International Journal of Hematology|March 7, 2021
Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantationToshihisa Nakashima, Yoshihiro Inamoto, Yayoi Fukushi, et al.International Journal of Hematology|March 5, 2021
New routes to eradicating chronic myelogenous leukemia stem cells by targeting metabolismKazuhito NakaInternational Journal of Hematology|November 5, 2021
Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patientsAkio Mori, Masahiro Onozawa, Daisuke Hidaka, et al.International Journal of Hematology|November 6, 2022
Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemiaMasamitsu Yanada, Satoshi Yamasaki, Takaaki Konuma, et al.International Journal of Hematology|November 1, 2022
Very early death within 30 days after diagnosis in patients with acute myeloid leukemiaMachiko Kusuda, Hideki Nakasone, Yuhei Nakamura, et al.International Journal of Hematology|October 1, 2022
Short-term efficacy of decitabine-based therapy in JMML: a retrospective study from a single center in ChinaYuli Cai, Jingliao Zhang, Meihui Yi, et al.International Journal of Hematology|October 2, 2022
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular diseaseOrly Leiva, Siyang Ren, Donna Neuberg, et al.International Journal of Hematology|October 1, 2022
Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequencyMichael J Hochman, B Douglas Smith, Theodoros Karantanos, et al.Pageof 548